GLP-2 TRZ
US$ 21.20
nausea and diarrhea on glp 1 GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists Managing GLP-1/GIP side effects with
Description
View at Publisher | View at Google Scholar Lee YS et al
A critical consideration is that diabetes itself substantially increases gastroparesis riskaffecting up to 5% of patients with type 1 diabetes and 1% with type 2 diabetes
JAMA 331(19):16721673
They do appear to be a reasonable second-line add-on therapy to metformin, especially in individuals at high risk for hypoglycemia (i.e
They also slow gastric emptying so food moves slower through the stomach
